High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

The objective of this study is to describe the characteristics and outcomes of rheumatic and musculoskeletal disease (RMD) patients who were treated with rituximab and had suspected or confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In this descriptive study, RMD pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Loarce-Martos, Jesús, García-Fernández, Antía, López-Gutiérrez, Fernando, García-García, Verónica, Calvo-Sanz, Laura, del Bosque-Granero, Iván, Terán-Tinedo, M. Andreína, Boteanu, Alina, Bachiller-Corral, Javier, Vázquez-Díaz, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499013/
https://www.ncbi.nlm.nih.gov/pubmed/32945944
http://dx.doi.org/10.1007/s00296-020-04699-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499013/
https://www.ncbi.nlm.nih.gov/pubmed/32945944
http://dx.doi.org/10.1007/s00296-020-04699-x

Ejemplares similares